Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Cancer vaccines: on the threshold of success.

Emens LA.

Expert Opin Emerg Drugs. 2008 Jun;13(2):295-308. doi: 10.1517/14728214.13.2.295 . Review.

2.

Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives.

Cecco S, Muraro E, Giacomin E, Martorelli D, Lazzarini R, Baldo P, Dolcetti R.

Curr Cancer Drug Targets. 2011 Jan;11(1):85-102. Review.

PMID:
21062241
3.

Toward a breast cancer vaccine: work in progress.

Emens LA, Jaffee EM.

Oncology (Williston Park). 2003 Sep;17(9):1200-11; discussion 1214, 1217-8. Review.

4.

Recent developments in therapeutic cancer vaccines.

Morse MA, Chui S, Hobeika A, Lyerly HK, Clay T.

Nat Clin Pract Oncol. 2005 Feb;2(2):108-13. Review.

PMID:
16264883
5.

Whole cell vaccines--past progress and future strategies.

Keenan BP, Jaffee EM.

Semin Oncol. 2012 Jun;39(3):276-86. doi: 10.1053/j.seminoncol.2012.02.007. Review.

6.

Cancer vaccines: what do we need to measure in clinical trials?

Kudrin A.

Hum Vaccin Immunother. 2014;10(11):3236-40. doi: 10.4161/hv.27586. Epub 2014 Nov 1. Review.

7.

Cancer vaccines: an old idea comes of age.

Emens LA, Jaffee EM.

Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S161-8. Review.

PMID:
14508095
8.

Vaccines: an innovative approach to treating cancer.

Pazdur MP, Jones JL.

J Infus Nurs. 2007 May-Jun;30(3):173-8. Review.

PMID:
17505219
9.

[Current status and future perspective of cancer vaccine development].

Sasada T, Itoh K.

Gan To Kagaku Ryoho. 2011 Apr;38(4):503-8. Review. Japanese.

PMID:
21498975
10.

Cancer vaccines entering Phase III clinical trials.

Durrant LG, Spendlove I.

Expert Opin Emerg Drugs. 2003 Nov;8(2):489-500. Review.

PMID:
14662001
11.

Roadmap to a better therapeutic tumor vaccine.

Emens LA.

Int Rev Immunol. 2006 Sep-Dec;25(5-6):415-43. Review.

PMID:
17169782
12.

Cancer vaccines: between the idea and the reality.

Finn OJ.

Nat Rev Immunol. 2003 Aug;3(8):630-41. Review.

PMID:
12974478
13.

Breast cancer vaccines: promise for the future or pipe dream?

Mittendorf EA, Peoples GE, Singletary SE.

Cancer. 2007 Oct 15;110(8):1677-86. Review.

14.

[Epitope peptide vaccine with oncoantigen for cancer and its biomarker].

Hazama S, Maeda K, Oka M.

Nihon Rinsho. 2012 Dec;70(12):2189-93. Review. Japanese.

PMID:
23259395
15.

Cancer immunoprevention: a new approach to intercept cancer early.

Umar A.

Cancer Prev Res (Phila). 2014 Nov;7(11):1067-71. doi: 10.1158/1940-6207.CAPR-14-0213. Epub 2014 Sep 18. Review.

16.

Current state of vaccine therapies in non-small-cell lung cancer.

Romero P.

Clin Lung Cancer. 2008 Feb;9 Suppl 1:S28-36. Review.

PMID:
18540532
17.

Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.

Gridelli C, Rossi A, Maione P, Ferrara ML, Castaldo V, Sacco PC.

Oncologist. 2009 Sep;14(9):909-20. doi: 10.1634/theoncologist.2009-0017. Epub 2009 Sep 2. Review.

18.

Progress on new vaccine strategies for the immunotherapy and prevention of cancer.

Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE, Morris JC.

J Clin Invest. 2004 Jun;113(11):1515-25. Review.

19.
20.

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.

Emens LA, Jaffee EM.

Cancer Res. 2005 Sep 15;65(18):8059-64. Review.

Supplemental Content

Support Center